Cadila Pharma launches novel three-dose rabies vaccine ThRabis
The recombinant nanoparticle-based rabies G protein vaccine is prepared using Virus-Like Particle technology
Source: biospectrumindia.com
Stay updated with breaking news from Sumit Poddar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The recombinant nanoparticle-based rabies G protein vaccine is prepared using Virus-Like Particle technology
In an important breakthrough, pharma major Cadila Pharmaceuticals has developed a novel three-dose recombinant nano-particle-based rabies G protein vaccine, ThRabis.